AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Aug 1, 2016
5262_dirs_2016-08-01_d08185e4-db64-41ae-9cd7-e47663d34fc4.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 8804F
GlaxoSmithKline PLC
01 August 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms C Thomas
b)
Position/status
Senior Vice President, Human Resources
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
The exercise of options over 20,180 Ordinary Shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £11.47 | 20,180 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-07-28
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms C Thomas
b)
Position/status
Senior Vice President, Human Resources
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Sale of 17,024 Ordinary Shares to satisfy option costs and the tax and NI liability arising following the exercise of options over 20,180 Ordinary Shares granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £17.0778 | 17,024 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-07-28
f)
Place of the transaction
London Stock Exchange (XLON)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms C Thomas
b)
Position/status
Senior Vice President, Human Resources
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
The exercise of options over 20,180 Ordinary Shares, granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £14.88 | 20,180 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-07-28
f)
Place of the transaction
n/a
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms C Thomas
b)
Position/status
Senior Vice President, Human Resources
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Sale of 19,235 Ordinary Shares to satisfy option costs and the tax and NI liability arising following the exercise of options over 20,180 Ordinary Shares granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £17.0814 | 19,235 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-07-28
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHZFLFBQVFLBBB
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'QPr6pb1P6Ef6Ev4HNJwCWzdtZfheNT57GXqJlUv6uHWP8sr-jlmuByGiF6edqfJwu8QF9YdZQxDiFUfesctDmr7neL_V5JhBxEoNS2dsJOY1:L7VYglIhCyqd39akJqvGa4FxSs_-L3C8IpcQOB2E40i7g7k2PIiVq57uMi_548v105yqz9wGEzgLZPFgVO9tC8ATxv9gpQ4nym4tVAJP2Nk1'}});//]]>